Navigation Links
Microchip Spots Stray Tumor Cells in the Bloodstream
Date:12/19/2007

Device might aid in the detection and monitoring of cancer, developers say

WEDNESDAY, Dec. 19 (HealthDay News) -- A U.S. team has developed a microchip device that can detect rare tumor cells lingering in the bloodstream.

The device has a silicon chip with about 80,000 microscopic posts. Each post is coated with an antibody to a particular protein expressed by most solid tumors. The device is able to capture, count and analyze circulating tumor cells (CTCs) from a blood sample, the researchers say.

CTCs are cells from solid tumors that circulate in the bloodstream at a level of one in a billion cells. Because they're rare and fragile, it's been impossible to use CTCs to help doctors make clinical decisions about cancer patients.

This new CTC-chip may prove effective in helping monitor and guide cancer treatment, said the team of researchers from the Massachusetts General Hospital (MGH) in Boston. A report on the new chip is published in the Dec. 20 issue of the journal Nature.

"This use of nanofluidics to find such rare cells is revolutionary, the first application of this technology to a broad, clinically important problem," Dr. Daniel Haber, director of the MGH Cancer Center and report co-author, said in a prepared statement.

"While much work remains to be done, this approach raises the possibility of rapidly and noninvasively monitoring tumor response to treatment, allowing changes if the treatment is not effective, and the potential of early-detection screening in people at increased risk for cancer," Haber said.

More information

The American Cancer Society has more about cancer.



-- Robert Preidt



SOURCE: Massachusetts General Hospital, news release, Dec. 19, 2007 '/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Microchip-based device can detect rare tumor cells in bloodstream
2. Test Spots Genetic Damage Done by Smoking
3. Gene-Based Screen Spots Cervical Cancer Earlier
4. Video Pill Spots Hidden Crohns Disease
5. Test Spots Who Should Get Implanted Defibrillator
6. New Test Criteria Spots Rheumatoid Arthritis Sooner
7. Topical treatment for age spots, from Harvard Womens Health Watch
8. Breast MRI spots other cancers, may alter treatment plan
9. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
10. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
11. Study details regulation of vital tumor suppressor gene p53
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2015)... 2015 Forbes Living is scheduled ... one which is synonymous with clean beaches, sparkling office buildings, ... are major economic influencers in the city on the Pacific ... show are pleased to announce the show will be broadcast ... 3:00 PM PDT. Tune in to find out what the ...
(Date:4/25/2015)... DC (PRWEB) April 26, 2015 The ... Seniors (ACE.S) , a national endeavor to prepare nurses ... adults, is a great success, according to a new ... the program's original funding partners. , The project ... of Philadelphia (CCP), under the direction of Elaine Tagliareni, ...
(Date:4/25/2015)... April 25, 2015 In observance of ... join The Million Nets Pledge, a two-year pledge by ... protect refugee families with one million bednets by 2016. ... work with UN partners to protect children, refugees, and ... , “There has been a large surge in ...
(Date:4/25/2015)... New York (PRWEB) April 25, 2015 ... established for vaginal mesh lawsuits filed against C.R. ... U.S. District Court, Southern District of West Virginia. ... a Scheduling Conference was convened that day, after ... Master Long Form Complaint. The Order directed that ...
(Date:4/25/2015)... Henderson, NV (PRWEB) April 25, 2015 ... Program is still eliciting the excitement of the public ... well into the months of May and June. ... Wellness™ held their biannual tradition of "Special Prayers." More ... who had attended previous Special Prayers and have reported ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4Health News:Trivedi Master Wellness™ Announces the Resounding Success of their Special Prayers Human Wellness Program 2Health News:Trivedi Master Wellness™ Announces the Resounding Success of their Special Prayers Human Wellness Program 3
... HealthDay Reporter , WEDNESDAY, Nov. 17 (HealthDay News) ... appear to be at higher risk for heart disease. ... with severe atherosclerosis (hardening of the arteries), as measured ... The condition "is emerging as a significant risk ...
... -- Resistance exercise such as weight training affects blood ... benefits, finds a new study. Researchers at the ... (vascular) responses to two types of moderate-intensity workouts: three ... 30 minutes of aerobic cycling. There were significant ...
... named Walter and Eliza Hall Institute researcher Dr Benjamin Kile ... Minister,s Prize for Life Scientist of the Year is awarded ... the potential to advance, human welfare. Dr Kile, ... be presented with the award tonight by the Hon. Kim ...
... Minn. -- With the 2010 election over and new ... to continue the discussion about patient-centered health care. In ... build a high-value health care system, the Mayo Clinic ... entitled "Achieving the Vision: Advancing High-Value ,Health Care." ...
... , WEDNESDAY, Nov. 17 (HealthDay News) -- The structure of ... researchers say. In their study, the investigators found that ... mammals compared to others and that the difference in growth ... the way it connects the mother and baby. The ...
... N.Y., Nov. 17, 2010 Eight states earned a better grade ... 32 others and the District of Columbia saw their preterm birth ... nation saw the first two-year decline in the preterm birth rate, ... rate dropped to 12.3 percent, from the 2006 final rate of ...
Cached Medicine News:Health News:Veterans With PTSD May Be at Higher Risk for Heart Disease 2Health News:Veterans With PTSD May Be at Higher Risk for Heart Disease 3Health News:Resistance Exercise May Offer Different Cardio Benefits 2Health News:Dr. Benjamin Kile named 2010 Australian Life Scientist of the Year 2Health News:Gestational Period Depends on Structure of Placenta: Research 2Health News:Preterm birth rates improve in most states 2
(Date:4/23/2015)...  AbbVie (NYSE: ABBV ) has announced that ... its New Drug Application (NDA) and granted priority review ... of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). The ... genotype 4 (GT4) hepatitis C virus (HCV) infection. ... being evaluated by the FDA for patients in ...
(Date:4/23/2015)... , April 23, 2015 Once again, ... strengthening our commitment to patient safety. BeaconMedaes, ... fight against infectious disease. The next generation ... Medical gas sensors are now mounted in the assembly, ... need to open ceiling tiles potentially releasing dust spores ...
(Date:4/23/2015)... FRANCISCO , April 23, 2015 Nektar Therapeutics ... the first quarter ended March 31, 2015 on Thursday, April ... Howard Robin , president and chief executive officer, will host ... p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... the conference call can be accessed through a link that ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7BeaconMedaes launches new Zone Valve Box Assembly 2Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets 2
... Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company ... from its consumer trial with Allumera™, a breakthrough cosmetic ... The RevitAll study was performed with a standard ... Allumera™ improves skin appearance, when compared to exposure by ...
... Inc. (Hologic or the Company) (Nasdaq: ... of premium diagnostics products, medical imaging systems and ... of women, announced today the U.S. Food and ... Makena™ (hydroxyprogesterone caproate injection), formerly known as Gestiva™. ...
Cached Medicine Technology:Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 2Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 3Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 4FDA Approves Hologic's Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical 2
Lyphochek Assayed Chemistry Control requires no special diluent and has good reconstituted stability for enzymes and CO2. It is assayed for most major instruments and methodologies....
Lyphochek Benzo/TCA Control Set A is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and tricyclic antidepressant drugs....
Lyphochek Benzo/TCA Control Set B is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and antidepressant drugs....
Lyphochek Therapeutic Drug Monitoring Control (TDM) contains over 40 analytes with assayed values at three clinically significant levels....
Medicine Products: